Latest news
AI can flag hidden cardiac risk. The dangerous part is what health systems do next
A new peer-reviewed review maps the growing use of artificial intelligence across ECG interpretation, cardiovascular imaging, arrhythmia detection, heart failure prediction and wearable monitoring. The technology is advancing rapidly. Evidence standards, accountability, reimbursement and care pathways are not.
Canada’s Generic Semaglutide Approval Tests GLP-1 Affordability
India’s Obesity Campaign Dispute Tests the Line Between Awareness and Promotion
England’s Tirzepatide Rollout Shows Approval Is Not Access
Medicare’s GLP-1 Bridge Turns Obesity Coverage Into a Public-Payer Experiment
WHO Makes Obesity Treatment a Global Access Test
Cyberbullying Becomes a Youth Mental Health Policy Target
Alzheimer’s Agitation Gets a New Drug, But Care Pathways Still Lag
Rare Epilepsy Moves Toward Treating the Cause
Huntington Gene Therapy Hits the Evidence Wall
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.